Abicipar for Neovascular AMD: Two-Year Results
Risk of Adverse Ocular Events With Brolucizumab
Corneal Stiffness Metrics Signal Glaucoma Progression
Machine Learning Predicts Anti-VEGF Treatment Demand
Social Work Program Boosts Adherence to Follow-Up Care
PAK Outcomes Are Better for Contact Lens Wearers
Ethnic Disparities in Clinical Trials of Ophthalmic Drugs
Older Drivers and Accidents
PEDIG Report: Lensectomy for Traumatic Cataract
Stroke Risk Soars After RAO
Correcting Hyperopia Improves Accommodative Function
All content on the Academy’s website is protected by copyright law and the Terms of Service. This content may not be reproduced, copied, or put into any artificial intelligence program, including large language and generative AI models, without permission from the Academy.